In this episode, I am joined by specialty pharmacist Michaela Wachal, PharmD, CSP, to discuss the safety concerns regarding aluminum adjuvants used in vaccines. We explore adjuvant levels present in vaccinations that exceed the FDA’s stated safety limits, differences in bioavailability between ingested vs. injected aluminum, and research findings showing elevated aluminum levels in post-mortem brain tissue of individuals with autism and other neurodegenerative disorders. This conversation emphasizes the importance of transparency, informed consent, and continued research into aluminum exposure.

Show Sources:

• FDA limits on aluminum exposure via parenteral nutrition to less than 5mcg/kg/day https://link.springer.com/rwe/10.1007/978-1-4614-7836-2_77
• CDC FOIA request response – CDC Unable to locate safety studies for aluminum adjuvants: https://icandecide.org/wp-content/uploads/2023/02/20190314-CDC-Final-Response-No-RecordsIR0083.pdf
• High levels of aluminum in brain tissue for autism and neurodegenerative disorders: https://www.sciencedirect.com/science/article/pii/S0946672X17308763

Follow Michaela Wachal, PharmD, on Instagram:

• https://www.instagram.com/yourclinicalpharmacist.wachal/
• https://yourclinicalpharmacist.start.page/

Functional medicine training for nurses:

• Interested in becoming a functional medicine nurse? Join Melissa live at the next webinar www.functionalnurseacademy.com/webinar-registration
• Learn more about the Functional Nurse Academy https://www.functionalnurseacademy.com

Functional medicine training for all other healthcare specialties and health and wellness coaches:

• https://www.christianfma.com